[The prognostic value of thrombus precursor protein in the assessment of the probability for venous thrombosis recurrence after the completion of anticoagulatory therapy with warfarin].
The article contains data on venous thrombosis (VT) recurrence rate in patients with the first episode of thrombus formation after the completion of one-year therapy with warfarin. The investigation included study of the prognostic value of intravascular coagulation marker (thrombus precursor protein --TPP) for the risk of venous retrombosis. The study showed that a high TPP level at the end of standard therapy course with warfarin in patients who had the first episode of spontaneous venous thrombosis is a significant indicator of a possible thrombosis recurrence during the nearest two tears after treatment with anticoagulants.